BackIntelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Overview

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Total Current Liabilities

Latest total current liabilities for IQMDU: $1.1M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$1.08M
355.39% YoYΔ $841828.00 vs prior year quarter

Peer average / median

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Total Current Liabilities History

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) vs. peers: Total Current Liabilities Comparison

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) (IQMDU) FAQ

The latest total current liabilities for IQMDU is $1.1M as of December 2022. That compares with $240K in the prior-year period — up 355.4% year over year. Investors often review this figure alongside Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, IQMDU's total current liabilities moved from $240K to $1.1M — a 355.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s operating scale or balance-sheet position.

A total current liabilities figure of $1.1M for IQMDU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IQMDU's total current liabilities ($1.1M), review year-over-year change from $240K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.